Búsqueda de un ensayo clínico
Otra(s) opcion(es) de búsqueda
5 Resultado(s)
Ensayo clínico en reclutamiento
= 
; Ensayos clínico en curso
= 
; Financiado por un miembro del IRDiRC = 
; Miembro de una ERN = 
Ensayo(s) clínico(s) nacional(es)
REINO UNIDO (EL)
South Glamorgan
CARDIFF
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study of the Efficacy and Safety of 2 Doses of Lenalidomide Versus Placebo in Red Blood Cell (RBC) Transfusion-Dependent Subjects With Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated With a Deletion (Del) 5q[31] Cytogenetic Abnormality (Phase III)
University Hospital of Wales
Department of Haematology
REINO UNIDO (EL)
South Glamorgan
CARDIFF
IPI-145-06 - A Phase 2 Study of IPI-145 in Subjects with Refractory Indolent Non-Hodgkin Lymphoma (DYNAMO) - UK
University Hospital of Wales
Department of Haematology
REINO UNIDO (EL)
South Glamorgan
CARDIFF
VALOR: A Phase 3, Randomized, Controlled, Double Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia - UK
University Hospital of Wales
Department of Haematology
REINO UNIDO (EL)
South Glamorgan
CARDIFF
A Phase 3 Open-Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First-line Treatment With or Without Hematopoietic Stem Cell Transplant (HSCT) Consolidation - UK
University Hospital of Wales
Department of Haematology
REINO UNIDO (EL)
South Glamorgan
CARDIFF